Watch Dr. William Wierda discuss how CAR T-cell therapy works as well as side effects caused by this cancer treatment.
MD Anderson’s patient-centric approach to research is advancing the understanding of malignant and non-malignant blood disorders and extending patients’ lives.
At the ASH Annual Meeting and Exposition, our experts showcase their practice-changing work with colleagues from across the globe for large-scale discussion.
Keep up with the latest from our experts presenting at the meeting and learn more about our pioneering hematology research below.
Two MD Anderson studies being presented at the 2019 ASH Annual Meeting and Exposition show combination therapies with promising results for leukemia and lymphoma patients.
MD Anderson researchers have developed a new immunotherapy by engineering chimeric antigen receptors into natural killer cells to target cancer, an approach in clinical trial against B-cell malignancies.
Meet Our Experts
Stop by booth 1461 to meet a few of our experts and discuss the latest blood cancers research and patient care.
Conferences and Educational Events
View a list of professional, CME-accredited conferences and educational events.
Moon Shots Program
Our intentions are noble – put blood cancers at the forefront of our investigation to make their cure a future reality. Our process is groundbreaking – use in-house, industry-quality platforms to ensure that our breakthrough discoveries aren’t left sitting in research labs.
By combining Innovation, Collaboration and Scale, the Moon Shots Program® is revolutionizing the conventional medical research approach to rapidly adapt pre-clinical findings into treatment options for challenging blood cancers.